Hakutulokset - Dirk‐Thomas Waldschmidt

  • Näytetään 1 - 3 yhteensä 3 tuloksesta
Tarkenna hakua
  1. 1
    Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort

    Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort Tekijä Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, Jan Best, Thorben Fründt, Carolin Czauderna, Alica K. Beutel, Dominik Bettinger, Johannes Weiß, Tobias Meischl, Fabian Kütting, Dirk‐Thomas Waldschmidt, Pompilia Radu, Michael Schultheiß, Kai‐Henrik Peiffer, Thomas Jens Ettrich, Arndt Weinmann, Henning Wege, Marino Venerito, Jean‐François Dufour, Christian M. Lange, Matthias Pinter, Oliver Waidmann

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

    Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score Tekijä Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Vera Himmelsbach, Kornelius Schulze, Johann von Felden, Thorben Fründt, Marc Stadler, Harald Heinzl, Kateryna Shmanko, Stephan Spahn, Pompilia Radu, Alexander Siebenhüner, Joachim C. Mertens, Nuh N. Rahbari, Fabian Kütting, Dirk‐Thomas Waldschmidt, Matthias P. Ebert, Andreas Teufel, Sara De Dosso, David J. Pinato, Tiziana Pressiani, Tobias Meischl, Lorenz Balcar, Christian Müller, Mattias Mandorfer, Thomas Reiberger, Michael Trauner, Nicola Personeni, Lorenza Rimassa, Michael Bitzer, Jörg Trojan, Arndt Weinmann, Henning Wege, Jean‐François Dufour, Markus Peck‐Radosavljevic, Arndt Vogel, Matthias Pinter

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    NASH limits anti-tumour surveillance in immunotherapy-treated HCC Tekijä Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, Olivier Govaere, Matthias Pinter, Marta Szydlowska, Revant Gupta, Mengjie Qiu, Aleksandra Deczkowska, Assaf Weiner, Florian L. Müller, Ankit Sinha, Ekaterina Friebel, Thomas Engleitner, Daniela Lenggenhager, Anja Moncsek, Danijela Heide, Kristin Stirm, Jan Kosla, Eleni Kotsiliti, Valentina Leone, Michael Dudek, Suhail Yousuf, Donato Inverso, Indrabahadur Singh, Ana Teijeiro, Florian Castet, Carla Montironi, Philipp K. Haber, Dina Tiniakos, Pierre Bédossa, Simon Cockell, Ramy Younes, Michèle Vacca, Fabio Marra, Jörn M. Schattenberg, Michael Allison, Elisabetta Bugianesi, Vlad Ratziu, Tiziana Pressiani, Antonio D’Alessio, Nicola Personeni, Lorenza Rimassa, Ann K. Daly, Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein, Arndt Vogel, Markus Peck‐Radosavljevic, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Jörg Trojan, Kornelius Schulze, Henning Wege, Sandra Koch, Arndt Weinmann, Marco Bueter, Fabian Rössler, Alexander Siebenhüner, Sara De Dosso, Jan‐Philipp Mallm, Viktor Umansky, Manfred Jugold, Tom Luedde, Andrea Schietinger, Peter Schirmacher, Brinda Emu, Hellmut G. Augustin, Adrian T. Billeter, Beat P. Müller‐Stich, Hiroto Kikuchi, Dan G. Duda, Fabian Kütting, Dirk-Thomas Waldschmidt, Matthias Ebert, Nuh N. Rahbari, Henrik E. Mei, Axel Schulz, Marc Ringelhan, Nisar P. Malek, Stephan Spahn, Michael Bitzer, Marina Ruiz de Galarreta, Amaia Lujambio, Jean‐François Dufour, Thomas U. Marron, Ahmed O. Kaseb, Masatoshi Kudo, Yi‐Hsiang Huang, Nabil Djouder, Katharina Wolter, Lars Zender, Patrice N. Marche, Thomas Decaens, David J. Pinato, Roland Rad, Joachim C. Mertens, Achim Weber, Kristian Unger

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: